title: Computational modelling and inhibitor risk: predicting the future?
authors.affiliation: Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK; The Royal London Hospital Haemophilia Centre, Barts Health NHS Trust, London, UK.
authors.forename: D P
authors.initials: DP
authors.lastname: Hart
mesh_terms: D005169:Factor VIII / Q000235:genetics* / Q000276:immunology*; D006467:Hemophilia A / Q000235:genetics* / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000235:genetics*; D006801:Humans; D007518:Isoantibodies / Q000276:immunology*; D020125:Mutation, Missense; D010446:Peptide Fragments / Q000276:immunology*
chemical_list: D000949:Histocompatibility Antigens Class II; D007518:Isoantibodies; D010446:Peptide Fragments; D005169:Factor VIII